Cargando…
Metabolic biomarkers for predicting cardiovascular disease
Cardiac and peripheral vascular biomarkers are increasingly becoming targets of both research and clinical practice. As of 2008, cardiovascular-related medical care accounts for greater than 20% of all the economic costs of illness in the United States. In the age of burgeoning financial pressures o...
Autores principales: | Montgomery, Jana E, Brown, Jeremiah R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3563347/ https://www.ncbi.nlm.nih.gov/pubmed/23386789 http://dx.doi.org/10.2147/VHRM.S30378 |
Ejemplares similares
-
Biomarkers Predictive of Metabolic Syndrome and Cardiovascular Disease in Childhood Cancer Survivors
por: Romano, Alberto, et al.
Publicado: (2022) -
Predictive and diagnostic biomarkers for gestational diabetes and its associated metabolic and cardiovascular diseases
por: Lorenzo-Almorós, A., et al.
Publicado: (2019) -
Novel biomarkers for cardiovascular risk prediction
por: Wang, Juan, et al.
Publicado: (2017) -
Endogenous Secretory RAGE as a Novel Biomarker for Metabolic Syndrome and Cardiovascular Diseases
por: Koyama, Hidenori, et al.
Publicado: (2007) -
Myocardial Biomarkers for Prediction of Cardiovascular Disease
por: Sundström, Johan
Publicado: (2009)